Pacific Bio (NASDAQ: PACB) reported Q2 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $20.7 million versus the consensus estimate of $20.19 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.